Johnson & Johnson’s latest prospective offering to the IL-23 psoriasis space—a Protagonist Therapeutics-partnered once-daily ...
1st in the world for Development Studies (QS World University Rankings by Subject 2024). Our four departments are in the UK's top 20 (QS University Rankings 2024). The School of Global Studies is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback